[How to act when an alpha-blocker is associated with a potent inhibitor of CYP3A4]. / Conduite à tenir en cas d'association d'un alpha-bloquant et d'un inhibiteur puissant du cytochrome 3A4.
Prog Urol
; 27(5): 275-282, 2017 Apr.
Article
in Fr
| MEDLINE
| ID: mdl-28365198
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Sulfonamides
/
Adrenergic alpha-Antagonists
/
Drug Interactions
/
Cytochrome P-450 CYP3A Inhibitors
/
Indoles
/
Ketoconazole
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
Fr
Journal:
Prog Urol
Journal subject:
UROLOGIA
Year:
2017
Type:
Article
Affiliation country:
France